Home LiteratureArticle Details
PMID: 14757696 Published · ppublish English Journal Article Research Support, U.S. Gov't, P.H.S.

Increased myocardial dysfunction after ischemia-reperfusion in mice lacking glucose-6-phosphate dehydrogenase.

Circulation ·Vol. 109 ·No. 7 ·2004-02-24 ·Pages 898-903

Jain M, Cui L, Brenner DA, Wang B, Handy DE, Leopold JA, Loscalzo J, Apstein CS, Liao R

Abstract

Free radical injury contributes to cardiac dysfunction during ischemia-reperfusion. Detoxification of free radicals requires maintenance of reduced glutathione (GSH) by NADPH. The principal mechanism responsible for generating NADPH and maintaining GSH during periods of myocardial ischemia-reperfusion remains unknown. Glucose-6-phosphate dehydrogenase (G6PD), the rate-limiting enzyme in the pentose phosphate pathway, generates NADPH in a reaction linked to the de novo production of ribose. We therefore hypothesized that G6PD is essential for maintaining GSH levels and protecting the heart during ischemia-reperfusion injury. Susceptibility to myocardial ischemia-reperfusion injury was determined in Langendorff-perfused hearts isolated from wild-type mice (WT) and mice lacking G6PD (G6PD(def)) (20% of WT myocardial G6PD activity). During global zero-flow ischemia, cardiac function was similar between WT and G6PD(def) hearts. On reperfusion, however, cardiac relaxation and contractile performance were greatly impaired in G6PD(def) myocardium, as demonstrated by elevated end-diastolic pressures and decreased percent recovery of developed pressure relative to WT hearts. Contractile dysfunction in G6PD(def) hearts was associated with depletion of total glutathione stores and impaired generation of GSH from its oxidized form. Increased ischemia-reperfusion injury in G6PD(def) hearts was reversed by treatment with the antioxidant MnTMPyP but unaffected by supplementation of ribose stores. These results demonstrate that G6PD is an essential myocardial antioxidant enzyme, required for maintaining cellular glutathione levels and protecting against oxidative stress-induced cardiac dysfunction during ischemia-reperfusion.

MeSH Terms
Animals Antioxidants/pharmacology,therapeutic use Female Genotype Glucosephosphate Dehydrogenase/genetics,physiology Glucosephosphate Dehydrogenase Deficiency/complications Glutathione/metabolism Male Metalloporphyrins/pharmacology,therapeutic use Mice Mice, Knockout Myocardial Contraction/drug effects,physiology Myocardial Ischemia/enzymology,genetics,physiopathology Myocardial Reperfusion Injury/enzymology,genetics,physiopathology NADP/physiology Oxidation-Reduction Ribose/deficiency,pharmacology
Chemicals
Antioxidants Metalloporphyrins NADP Ribose tetrakis(N-methyl-4-pyridiniumyl)porphine manganese(III) complex Glucosephosphate Dehydrogenase Glutathione
Authors & Affiliations
9 authors, click to expand affiliations / ORCID
Jain Mohit
Whitaker Cardiovascular Institute and Evans Department of Medicine, Boston University School of Medicine, Boston, Mass 02118, USA.
Cui Lei
Brenner Daniel A
Wang Bo
Handy Diane E
Leopold Jane A
Loscalzo Joseph
Apstein Carl S
Liao Ronglih
Article Info
Journal
Circulation
Abbr.
Circulation
ISSN
1524-4539
Published
2004-02-24
Epub
2004-00-02
Pages
898-903
Language
English
Region
United States
NLM ID
0147763
Subset
IM
Grants
NHLBI NIH HHS · HL-004399 · United States
NHLBI NIH HHS · HL-007224 · United States
NHLBI NIH HHS · HL-055993 · United States
NHLBI NIH HHS · HL-058976 · United States
NHLBI NIH HHS · HL-061795 · United States
NHLBI NIH HHS · HL-067297 · United States
NHLBI NIH HHS · HL-073756 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: product@genelibs.com